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Accurate detection and quantification of microbiological contaminations remains an 
issue mainly due the lack of rapid and precise analytical techniques. Standard methods 
are expensive and time-consuming being associated to high economic losses and public 
health threats. In the context of pharmaceutical industry, the development of fast analytical 
techniques able to overcome these limitations is crucial and spectroscopic techniques 
might constitute a reliable alternative.
In this work we tested the ability of Fourier transform near infrared spectroscopy (FT-NIRS)
combined with several chemometric methods as partial least squares discriminant analysis 
(PLSDA) and partial least squares (PLS) to detect and quantify bacteria (Bacillus subtilis, 
Escherichia coli, Pseudomonas fluorescens, Salmonella enterica, Staphylococcus epidermidis) 
in sterile saline solutions (NaCl 0.9%). 
PLSDA models showed that FT-NIRS was able to discriminate between sterile and 
contaminated solutions for all bacteria as well as to identify contaminant bacteria. The 
PLS models allowed bacterial quantification (from 10-108 CFUs/mL) with limits of detection 
ranging from 5.1 to 9 for E. coli and B. subtilis, respectively. This methodology was also 
successfully validated in three pharmaceutical preparations (contact lens solution, cough 
syrup, topic anti-inflammatory solution).
Despite the need of some additional studies to strength the findings of this work, FT-NIRS 
seems to possess a high potential to be routinely used for the detection and quantification 
of bacterial contaminations in the pharmaceutical industry.
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